Mary Barra made history by working her way into Detroit�� car-guy club and becoming the first female CEO of General Motors. Now can she fix the company?
Mary Barra, mother of two and the first female CEO of General Motors General Motors, sat silently while the parents of ten dead children unloaded their grief and anger on her. Some read prepared statements; others spoke off the cuff. One father unbuttoned his dress shirt to reveal his daughter�� face on the T-shirt underneath. All were strangers but shared a tragic bond: Their loved ones died in a GM vehicle.
Renee Trautwein�� daughter, Sarah, 19, completed only one semester at her dream college before her 2005 Chevrolet Cobalt hit a tree. The air bag didn�� deploy. Doug Weigel�� daughter, Natasha, 18, died in Wisconsin after the 2005 Cobalt she was riding in crashed into a ditch. Randal Rademaker�� 15-year-old daughter, Amy, perished in the same crash. Susan Hayes��son, Ryan Quigley, 23, died in upstate New York when his 2007 Cobalt landed upside down in a shallow stream.
Top 5 Telecom Stocks To Invest In 2015: pSivida Corp.(PSDV)
pSivida Corp., together with its subsidiaries, develops drug delivery products for treatment of back-of-the-eye diseases that are administered by implantation, injection, or insertion. The company?s lead product candidate includes Iluvien, which is in Phase III clinical trials and delivers fluocinolone acetonide (FA) for the treatment of diabetic macular edema (DME), a cause of vision loss. It is also conducting Phase II clinical trials with Iluvien for the treatment of wet and dry form of age-related macular degeneration, and retinal vein occlusion. In addition, the company?s products include Retisert for the treatment of posterior uveitis, an autoimmune condition characterized by inflammation of the posterior of the eye that can cause sudden or gradual vision loss; and Vitrasert for cytomegalovirus retinitis, a blinding eye disease that occurs in individuals with advanced AIDS. It is developing the Latanoprost product, an injectable, bioerodible drug delivery implant i n Phase I/II dose-escalating study for the treatment of glaucoma and ocular hypertension; the Posterior Uveitis product candidate in a Phase I/II study for the treatment of posterior uveitis; BioSilicon technology system, which is nano-structured porous silicon designed for use as a drug delivery platform and to deliver smaller molecules; and Tethadur, which utilizes BioSilicon to deliver large biologic molecules, including peptides and proteins. It has strategic collaborations with Bausch & Lomb Incorporated; Alimera Sciences, Inc.; Pfizer, Inc.; and Intrinsiq Materials Cayman Limited. The company was founded in 1987 and is headquartered in Watertown, Massachusetts.
Advisors' Opinion:- [By Smith On Stocks]
This note focuses on the implications of the complete response letter (CRL) received by Alimera (ALIM) for Iluvien. This product was developed by pSivida (PSDV) but was partnered with Alimera. This report deals only with the investment significance for pSivida.
- [By John Kell]
Specialty pharmaceutical firm pSivida Corp.(PSDV) said the U.S. Food and Drug Administration didn’t approve a treatment for an eye disease found in patients with diabetes. The company’s stock tumbled 47% to $2 premarket, while shares of Alimera Sciences Inc.(ALIM) were down 39% to $1.66, as the treatment is licensed and sold by Alimera in other markets.
Hot Up And Coming Stocks To Own For 2014: On Assignment Inc.(ASGN)
On Assignment, Inc., a diversified professional staffing firm, provides flexible and permanent staffing solutions in the United States, Europe, Canada, Australia, and New Zealand. The company?s Life Sciences segment provides contract and permanent life science professionals to clients in the biotechnology, pharmaceutical, food and beverage, personal care, chemical, medical device, automotive, municipal, education, and environmental industries. Its contract professionals include chemists, clinical research associates, clinical lab assistants, engineers, biologists, biochemists, microbiologists, molecular biologists, biostatisticians, drug safety specialists, SAS programmers, medical writers, food scientists, regulatory affairs specialists, lab assistants, and other skilled scientific professionals. The company?s Healthcare segment offers locally-based and traveling contract professionals that include nurses, specialty nurses, respiratory therapists, surgical technicians, imaging technicians, X-ray technicians, medical technologists, medical assistants, pharmacists, pharmacy technicians, respiratory therapists, phlebotomists, coders, billers, claims processors, and collections staff, as well as dental professionals. This segment serves hospitals, integrated delivery systems, imaging centers, clinics, physician offices, reference laboratories, universities, managed care organizations, and third-party administrators. Its Physician segment provides short and long-term locum tenens services, and full-service physician search and consulting services. The company?s IT and Engineering segment offers high-end contract and direct placement services of information technology and engineering professionals with expertise in specialized information technology; software and hardware engineering; and mechanical, electrical, validation, and telecommunications engineering fields. On Assignment, Inc. was founded in 1985 and is headquartered in Calabasas, Cali fornia.
Advisors' Opinion:- [By Garrett Cook]
On Assignment (NYSE: ASGN) shares tumbled 22.61 percent to $27.01 after the company reported Q2 earnings of $0.56 per share on revenue of $468.60 million. Baird downgraded the stock from Outperform to Neutral.
Hot Up And Coming Stocks To Own For 2014: Accretive Health Inc. (AH)
Accretive Health, Inc. provides revenue cycle management services for hospitals and healthcare providers in the United States. It offers integrated revenue cycle management services that help healthcare providers to manage their revenue cycles, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation, and collections; quality and total cost of care services, which enable healthcare providers to manage the health of a defined patient population by identifying those individuals who are most likely to experience an adverse health event; and physician advisory services. Accretive Health, Inc. serves multi-hospital systems, including faith-based or community healthcare systems, academic medical centers, independent ambulatory clinics, and physician practice groups. The company was formerly known as Healthcare Services, Inc. and changed its name to Accretive Health, Inc. in August 2009. Accretive Healt h, Inc. was founded in 2003 and is headquartered in Chicago, Illinois.
Advisors' Opinion:- [By Jon C. Ogg]
Accretive Health Inc. (NYSE: AH) was downgraded to Neutral from Outperform at Credit Suisse.
Beam Inc. (NYSE: BEAM) was downgraded to Hold from Buy based on valuation at Argus.
Hot Up And Coming Stocks To Own For 2014: Bluforest Inc (BLUF)
Bluforest Inc., formerly Greenwood Gold Resources, Inc., incorporated on March 26, 2008, is a carbon offset credit trading company with land assets in South America. Global Environmental Investments Limited (GEIL) sold all of the rights and interests held by GEIL pursuant to the Acquisition Agreement, on March 30, 2012, to the Company regarding the Property, which consists of approximately 105,000 hectares. It consists of 100% of GEIL�� rights, title and interests in and to the timber, minerals, substances and the rights to receive from the Property, and 100% of the right, title and interests of GEIL in all existing oil, gas and/or mineral unitization, pooling and/or communization agreements, declarations, and/or orders and the properties covered or included in the units, which relate to the Property.
The Property consists of 100% of the right, title and interests of GEIL in all existing and agreements, including sales and sales related contracts, operating agreements and other agreements and contracts, which relate to Fundacion Nelson Velasco Aguirre (NVA), the Property or which relate to the exploration, development, operation or maintenance of the Property or the treatment, storage, transaction or marketing of production from or allocated to the Property. The 105,000 hectares also consists of 100% of the right, title and interests of GEIL in and to all materials, supplies, machinery, equipment, improvements, and other personal property and fixtures relating to the Property, and all wells, wellhead equipment, pumping units, flow lines, tanks, buildings, injection facilities, salt water disposal facilities, compression facilities, gathering systems and other equipment, all easements, rights-of-way, surface leases and other surface rights, all permits and licenses and all other appurtenances, used or held for use in connection with or related to the exploration, development, operation or maintenance of any of the Property.
Advisors' Opinion:- [By Peter Graham]
Small cap green stocks Eco-Tek Group Inc (OTCMKTS: ETEK) and BluForest Inc (OTCMKTS: BLUF) have been getting some attention lately thanks to some green���as in paid for promotions. Of course, there is nothing wrong with properly disclosed promotions, but one of these stocks happens to be getting a considerable amount of attention as its been the subject of numerous transactions. With that in mind, will investors see some green with these green small cap stocks? Here is a quick reality check:�
- [By Peter Graham]
Small cap stocks BluForest Inc (OTCMKTS: BLUF), Dephasium Corp (OTCMKTS: DPHS) and IceWEB, Inc (OTCBB: IWEB) have been getting some attention for at least a few weeks now thanks to paid for promotional activity. Of course, there is nothing wrong with properly disclosed stock promotions, but one of these stocks also has a former shareholder who has filed a civil action against it alleging there is an illegal ��ump and dump��scheme going on. So what�� the whole story and more importantly, what will happen with these small cap stocks when the well from promoters eventually goes dry? Here is a closer look and a quick reality check:
No comments:
Post a Comment